Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

ITRM — Iterum Therapeutics PLC Dilution Risk Tracker

Track ITRM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ITRM — Get alerts when the score changes →

As of August 28, 2026, Iterum Therapeutics PLC (ITRM) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Iterum Therapeutics PLC has a market capitalization of $1.60M, 44.66M shares outstanding, 18 institutional holders tracked. Stored dilution-related fields include 25.3K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
85
📊Float Risk
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 45%
🔄 Reverse Split model est. 70%
• 50-day avg $0.21 below $1 exchange minimum
• Only 4 months cash — financial pressure
💰 Capital Raise model 35%
• Low cash runway: 4 months remaining
🔔 Track ITRM — Get forecast alerts →

Market Data

Market Cap$1.60M
Shares Outstanding44.66M
FloatN/A
Cash$11.00M
Debt$13.08M
Short InterestN/A

Institutional Holdings

QoQ: ↓ 5.6% shares (2026Q1 vs prior)
18 institutional holders · 1.44M shares
#1 HRT FINANCIAL LP 890.1K shares
#2 CAPTRUST FINANCIAL ADVISORS 138.6K shares
#3 Gen-Wealth Partners Inc 82.6K shares
+ 15 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL WARRANT 2025-04-28
xbrl XBRL CONVERTIBLE 2023-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual ITRM Dilution Snapshot

Iterum Therapeutics PLC (ITRM) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ITRM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ITRM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note